drugset
drugset / Trial / NCT02908126

Compare Efficacy of Oxytocin Administrations on Postpartum Uterine Contractility

NCT02908126 ↗

Phase 1 Terminated 4 enrolled Oxytone Bioscience BV
RandomizedParallel-groupOpen-labelPrevention

Summary

This is a Phase I open-label, parallel-group clinical study in healthy term pregnant females undergoing a caesarean section. Two administrations of oxytocin will be tested, after which uterine contractility will be assessed.

Timeline

Start
2018-04-03
Primary completion
2019-06-27
Completion
2019-06-27

Outcome

Outcome not reported

Stopped: “No approval CA (MPA) of protocol amendment”

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide — Intravenous

Indications

No indication recorded.